Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Sep 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109487701000001112 | Dinutuximab beta (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 109487801000001115 | Dinutuximab beta | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dinutuximab beta | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Dinutuximab beta | Is a | Product containing monoclonal antibody | true | Inferred relationship | Existential restriction modifier | ||
| Dinutuximab beta | Has active ingredient | Monoclonal antibody | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dinutuximab beta 20mg/4.5ml solution for infusion vials | Is a | True | Dinutuximab beta | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR